NASDAQ: GBT       Global Blood Ther
Last Price Today's Change   Day's Range   Trading Volume
66.80   -0.04 (0.06%)  65.75 - 70.98  64,054


Avg Volume (4 weeks):814,215
4 Weeks Range:65.75 - 81.79
4 Weeks Price Volatility (%):
52 Weeks Range:39.95 - 87.54
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3476  2128  470  2881 

Top 10 Active Counters
 CIDM 4.14+2.83 
 VISL 0.896+0.471 
 GNUS 8.04+0.11 
 XSPA 1.85+0.77 
 AVP 5.60-0.05 
 NIO 5.86+0.26 
 AAL 13.765+1.915 
 AABA 19.630.00 
 TGE 22.39+0.81 
 AKRX 0.09-0.094 
Partners & Brokers